Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Por um escritor misterioso
Descrição
Researchers discover potent inhibitors of SARS-CoV-2 main protease
Frontiers An Integrated Computational and Experimental Approach
Potent and selective covalent inhibition of the papain-like
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main
Discovery of novel non-peptidic and non-covalent small-molecule
SARS‐CoV‐2 main protease inhibitors: What is moving in the field
Identification of Potent COVID-19 Main Protease (Mpro) Inhibitors
Discovery of quinazolin-4-one-based non-covalent inhibitors
Team CDD Company on LinkedIn: Open science discovery of potent
Open science discovery of potent noncovalent SARS-CoV-2 main
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel
Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS
Open science discovery of potent noncovalent SARS-CoV-2 main
Frontiers Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral
de
por adulto (o preço varia de acordo com o tamanho do grupo)